Skip to main content

Resveratrol binds and activates RKIP protein in colorectal cancer

Amino Acids volume 52, pages 1299–1306 (2020)Cite this article

Abstract

Raf-1 kinase inhibitory protein (RKIP) acts as a tumor cell metastasis suppressor and prognostic indicator for survival in various cancers. Its use is predicted to improve therapy for various malignancies, including colorectal cancer (CRC). RKIP, frequently denoted as phosphatidylethanolamine-binding protein 1, is expressed in all normal mammalian tissues. RKIP functions as an inhibitor of the Raf-1, PI-3K, and MAP kinase (MAPK) pathways. In this study, we found that resveratrol induced the expression of RKIP at protein levels. To elucidate the structural basis of the interaction between resveratrol and RKIP, we performed computational studies that explore the binding affinity and ligand efficacy of resveratrol against RKIP. This study reveals the prognostic significance of RKIP metastasis suppressor activity against CRC and its structural arrangements during drug–target interactions.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

Abbreviations

AA:

Amino acids

CASTp:

Computed Atlas of Surface Topography of Proteins

COX-2:

Cyclooxygenase-2

CRC:

Colorectal cancer

GPCR:

G protein-coupled receptor

GRK2:

G protein-coupled receptor kinases

HPV:

Human papillomavirus

iNOS:

Inducible nitric oxide synthase

MAPK:

Mitogen-activated protein kinases

MMP:

Matrix metalloproteinases

NF-κB:

Nuclear factor kappa B

PDB:

Protein Data Bank

PEBP1:

Phosphatidylethanolamine-binding protein

PGE2:

Prostaglandin E2

PKC:

Protein kinase C

PPARα:

Peroxisome proliferator-activated receptor α

ProSA:

Protein structure analysis

PTEN:

Phosphatase and tensin homolog

PTK:

Protein tyrosine kinase

pTyr:

Phospho tyrosine

QMEAN:

Qualitative model energy analysis

RCSB:

Research Collaboratory for Structural Bioinformatics

RKIP:

Raf-1 kinase inhibitory protein

SIRT1:

Sirtuin

SMILES:

Simplified molecular input line entry System

STAT:

Signal transducer and activators of transcription

VEGF:

Vascular endothelial growth factor

References

  • Al-Mulla F, Hagan S, Behbehani AI, Bitar MS, George SS, Going JJ, García JJC, Scott L, Fyfe N, Murray GI (2006) Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol 24(36):5672–5679

    CAS  Article  Google Scholar 

  • Al-Mulla F, Bitar MS, Al-Maghrebi M, Behbehani AI, Al-Ali W, Rath O, Doyle B, Tan KY, Pitt A, Kolch W (2011) Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3β. Cancer Res 71(4):1334–1343

    CAS  Article  Google Scholar 

  • Atmanene C, Laux A, Glattard E, Muller A, Schoentgen F, Metz-Boutigue M-H, Aunis D, Van Dorsselaer A, Stefano GB, Sanglier-Cianferani S (2009) Characterization of human and bovine phosphatidylethanolamine-binding protein (PEBP/RKIP) interactions with morphine and morphine-glucuronides determined by noncovalent mass spectrometry. Med Sci Monit 15(7):BR178–BR187

    CAS  PubMed  Google Scholar 

  • Banaganapalli B, Mulakayala C, Gowsia D, Mulakayala N, Pulaganti M, Shaik NA, Anuradha C, Rao RM, Al-Aama JY, Chitta SK (2013) Synthesis and biological activity of new resveratrol derivative and molecular docking: dynamics studies on NFkB. Appl Biochem Biotechnol 171(7):1639–1657

    CAS  Article  Google Scholar 

  • Battaini F, Mochly-Rosen D (2007) Happy birthday protein kinase C: past, present and future of a superfamily. Pharmacol Rese Off J Ital Pharmacol Soc 55(6):461

    CAS  Google Scholar 

  • Benkert P, Tosatto SC, Schomburg D (2008) QMEAN: a comprehensive scoring function for model quality assessment. Proteins Struct Funct Bioinform 71(1):261–277

    CAS  Article  Google Scholar 

  • Berretta M, Bignucolo A, Di Francia R, Comello F, Facchini G, Ceccarelli M, Iaffaioli RV, Quagliariello V, Maurea N (2020) Resveratrol in cancer patients: from bench to bedside. Int J Mol Sci 21(8):2945

    CAS  Article  Google Scholar 

  • Dadvar P, Kovanich D, Folkers GE, Rumpel K, Raijmakers R, Heck AJ (2009) Phosphatidylethanolamine-binding proteins, including RKIP, exhibit affinity for phosphodiesterase-5 inhibitors. ChemBioChem 10(16):2654–2662

    CAS  Article  Google Scholar 

  • Fang J-Y, Li Z-H, Li Q, Huang W-S, Kang L, Wang J-P (2012) Resveratrol affects protein kinase C activity and promotes apoptosis in human colon carcinoma cells. Asian Pac J Cancer Prev 13(12):6017–6022

    Article  Google Scholar 

  • Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z, Keller ET (2003) Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 95(12):878–889

    CAS  Article  Google Scholar 

  • Gambini J, Inglés M, Olaso G, Lopez-Grueso R, Bonet-Costa V, Gimeno-Mallench L, Mas-Bargues C, Abdelaziz K, Gomez-Cabrera M (2015) Vina J (2015) Properties of resveratrol: in vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans. Oxid Med Cell Longev. 2015:837042. https://doi.org/10.1155/2015/837042 (Epub 2015 Jun 28)

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  • Granovsky AE, Clark MC, McElheny D, Heil G, Hong J, Liu X, Kim Y, Joachimiak G, Joachimiak A, Koide S (2009) Raf kinase inhibitory protein function is regulated via a flexible pocket and novel phosphorylation-dependent mechanism. Mol Cell Biol 29(5):1306–1320

    CAS  Article  Google Scholar 

  • Guo C, Chang T, Sun T, Wu Z, Dai Y, Yao H, Lin D (2018) Anti-leprosy drug Clofazimine binds to human Raf1 kinase inhibitory protein and enhances ERK phosphorylation. Acta Biochim Biophys Sin 50(10):1062–1067

    CAS  Article  Google Scholar 

  • Hu C-j, Zhou L, Cai Y (2014) Dihydroartemisinin induces apoptosis of cervical cancer cells via upregulation of RKIP and downregulation of bcl-2. Cancer Biol Ther 15(3):279–288

    CAS  Article  Google Scholar 

  • Kopp P (1998) Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the ‘French paradox’? Eur J Endocrinol 138(6):619–620

    CAS  Article  Google Scholar 

  • Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ, Watanabe T (2015) Colorectal cancer. Nat Rev Dis Primers 1:15065. https://doi.org/10.1038/nrdp.2015.65

    Article  PubMed  PubMed Central  Google Scholar 

  • Kumar S, Jena L, Sahoo M, Kakde M, Daf S, Varma AK (2015) In silico docking to explicate interface between plant-originated inhibitors and E6 oncogenic protein of highly threatening human papillomavirus 18. Genom Inform 13(2):60

    Article  Google Scholar 

  • Laskowski RA, Swindells MB (2011) LigPlot+: multiple ligand–protein interaction diagrams for drug discovery. ACS Publications, Washington

    Google Scholar 

  • Li F-F, Song S-J, Zhang R-N (2009a) Phosphatidylethanolamine-binding protein (PEBP) in basic and clinical study. Sheng li ke xue jin zhan [Prog Physiol] 40(3):214–218

    CAS  Google Scholar 

  • Li HZ, Gao Y, Zhao XL, Liu YX, Sun BC, Yang J, Yao Z (2009b) Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer. Mol Cancer Res 7(6):832–840

    CAS  Article  Google Scholar 

  • Lorenz K, Lohse MJ, Quitterer U (2003) Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 426(6966):574

    CAS  Article  Google Scholar 

  • Nagaraju GP, Long TE, Park W, Landry JC, Taliaferro-Smith L, Farris AB, Diaz R, El-Rayes BF (2015) Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer. Mol Carcinog 54(10):1147–1158

    CAS  Article  Google Scholar 

  • Pany S, Majhi A, Das J (2012) PKC activation by resveratrol derivatives with unsaturated aliphatic chain. PLoS One 7(12):e52888

    CAS  Article  Google Scholar 

  • Park D, Jeong H, Lee MN, Koh A, Kwon O, Yang YR, Noh J, Suh P-G, Park H, Ryu SH (2016) Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition. Sci Rep 6:21772

    CAS  Article  Google Scholar 

  • Pathak RK, Baunthiyal M, Taj G, Kumar A (2014) Virtual screening of natural inhibitors to the predicted HBx protein structure of Hepatitis B Virus using molecular docking for identification of potential lead molecules for liver cancer. Bioinformation 10(7):428

    Article  Google Scholar 

  • Pervaiz S (2003) Resveratrol: from grapevines to mammalian biology. FASEB J 17(14):1975–1985

    CAS  Article  Google Scholar 

  • Pontius J, Richelle J, Wodak SJ (1996) Deviations from standard atomic volumes as a quality measure for protein crystal structures. J Mol Biol 264(1):121–136

    CAS  Article  Google Scholar 

  • Shemon AN, Eves EM, Clark MC, Heil G, Granovsky A, Zeng L, Imamoto A, Koide S, Rosner MR (2009) Raf Kinase Inhibitory Protein protects cells against locostatin-mediated inhibition of migration. PLoS One 4(6):e6028

    Article  Google Scholar 

  • Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70(1):7–30

    Article  Google Scholar 

  • Simister PC, Burton NM, Brady RL (2011) Phosphotyrosine recognition by the Raf kinase inhibitor protein. In: Forum on immunopathological diseases and therapeutics, 2011, vol 1. Begel House Inc., New York, pp 59–70. https://doi.org/10.1615/ForumImmunDisTher.v2.i1.70

  • Slater SJ, Seiz JL, Cook AC, Stagliano BA, Buzas CJ (2003) Inhibition of protein kinase C by resveratrol. Biochim Biophys Acta Mol Basis Dis 1637(1):59–69

    CAS  Article  Google Scholar 

  • Stewart JR, Ward NE, Ioannides CG, O’Brian CA (1999) Resveratrol preferentially inhibits protein kinase C-catalyzed phosphorylation of a cofactor-independent, arginine-rich protein substrate by a novel mechanism. Biochemistry 38(40):13244–13251

    CAS  Article  Google Scholar 

  • Sun AY, Simonyi A, Sun GY (2002) The “French Paradox” and beyond: neuroprotective effects of polyphenols. Free Radic Biol Med 32(4):314–318

    CAS  Article  Google Scholar 

  • Takizawa Y, Nakata R, Fukuhara K, Yamashita H, Kubodera H, Inoue H (2015) The 4′-hydroxyl group of resveratrol is functionally important for direct activation of PPARα. PLoS One 10(3):e0120865

    Article  Google Scholar 

  • Thakkar K, Geahlen RL, Cushman M (1993) Synthesis and protein-tyrosine kinase inhibitory activity of polyhydroxylated stilbene analogs of piceatannol. J Med Chem 36(20):2950–2955

    CAS  Article  Google Scholar 

  • Tohdoh N, Tojo S, Agui H, Ojika K (1995) Sequence homology of rat and human HCNP precursor proteins, bovine phosphatidylethanolamine-binding protein and rat 23-kDa protein associated with the opioid-binding protein. Mol Brain Res 30(2):381–384

    CAS  Article  Google Scholar 

  • Vastano BC, Chen Y, Zhu N, Ho C-T, Zhou Z, Rosen RT (2000) Isolation and identification of stilbenes in two varieties of Polygonum cuspidatum. J Agric Food Chem 48(2):253–256

    CAS  Article  Google Scholar 

  • Wallner B, Elofsson A (2006) Identification of correct regions in protein models using structural, alignment, and consensus information. Protein Sci 15(4):900–913

    CAS  Article  Google Scholar 

  • Wang Y, Catana F, Yang Y, Roderick R, van Breemen RB (2002) An LC-MS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine. J Agric Food Chem 50(3):431–435

    CAS  Article  Google Scholar 

  • Wang Y, Wang L-Y, Feng F, Zhao Y, Huang M-Y, Shao Q, Chen C, Sheng H, Chen D-L, Zeng Z-L (2015) Effect of Raf kinase inhibitor protein expression on malignant biological behavior and progression of colorectal cancer. Oncol Rep 34(4):2106–2114

    CAS  Article  Google Scholar 

  • Wiederstein M, Sippl MJ (2007) ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 35(suppl_2):W407–W410

    Article  Google Scholar 

  • Yeung K, Seitz T, Li S, Janosch P, McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H (1999) Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401(6749):173

    CAS  Article  Google Scholar 

  • Yousuf S, Duan M, Moen EL, Cross-Knorr S, Brilliant K, Bonavida B, LaValle T, Yeung KC, Al-Mulla F, Chin E (2014) Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer. PLoS One 9(3):e92478

    Article  Google Scholar 

Download references

Funding

None.

Author information

Affiliations

  1. Department of Bioscience and Biotechnology, Banasthali University, Vanasthali, Rajasthan, 304022, India

    Begum Dariya, Gowru Srivani & Afroz Alam

  2. Biomedical Informatics Centre, ICMR-Regional Medical Research Centre, Bhubaneswar, Odisha, 751 023, India

    Santosh Kumar Behera

  3. Department of Biotechnology, Jawaharlal Nehru Technological University, Hyderabad, Telangana, 500085, India

    Sheik Aliya

  4. Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, 30322, USA

    Ganji Purnachandra Nagaraju

Authors
  1. Begum Dariya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Santosh Kumar Behera
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gowru Srivani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sheik Aliya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Afroz Alam
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ganji Purnachandra Nagaraju
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Data processing: BD, SKB, GS, AA and GPN. Study design: BD, SA, AA and GPN. Experimental studies: BD, SKB, GS, GC, SA, and AA. Manuscript editing: BD, GS, GC, SA, AA and GPN.

Corresponding author

Correspondence to Ganji Purnachandra Nagaraju.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interest.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Handling Editor: A. G. de Brevern.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Dariya, B., Behera, S.K., Srivani, G. et al. Resveratrol binds and activates RKIP protein in colorectal cancer. Amino Acids 52, 1299–1306 (2020). https://doi.org/10.1007/s00726-020-02889-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00726-020-02889-2

Keywords

  • RKIP
  • Resveratrol
  • Colorectal cancer
  • Computational studies
  • Metastasis